 Benchtop Lab Equipment Reports Record Revenues and Earnings Bioprocessing Focused On Integration of Aquila Biolabs Acquisition BOHEMIA, NY ACCESSWIRE October 15, 2021 Scientific Industries, Inc. OTCQB:SCND, a life sciences tool provider, and a developer of digitally simplified bioprocessing products, today reported financial results for its fiscal year 2021 ended June 30, 2021. Financial Highlights - Fiscal 2021 Compared to Fiscal 2020: Net revenues were 9.8 million in Fiscal 2021, an increase of 2 million, or 26, compared to 7.8 million in Fiscal 2020 Gross profit was 5.0 million in Fiscal 2021, an increase of 1.1 million, or 28, versus 3.9 million in Fiscal 2020 Benchtop Laboratory Equipment EBIDTA was 1.6 million in Fiscal 2021, an increase of 1 million, or 200, compared to 0.6 million in Fiscal 2020 Cash and cash equivalents and investments were 13.4 million in Fiscal 2021, an increase of 5.5 million, or 70, versus 7.9 million in Fiscal 2020 Working capital was 16.1 million in Fiscal 2021, an increase of 5.6 million, or 53, compared to 10.5 million in Fiscal 2020 Management Discussion Helena Santos, Chief Executive Officer of Scientific Industries, stated, We are pleased with the record performance from our core Benchtop Laboratory Equipment Operations, which in part, enables us to support the future growth of our Bioprocessing business. 